15 December 2011
Lectus Therapeutics sprzedaje kluczowe aktywa farmaceutyczne
(Lectus Therapeutics sells key pharmaceutical assets; press release for Polish Market)

22 November 2011
UCB acquires Lectus Therapeutics’ key pharmaceutical assets

13 October 2010
Lectus PLC, the UK biotechnology company, has announced plans for a Q4 listing on NewConnect, the alternative market of the Warsaw Stock Exchange.

13 October 2010
Lectus PLC, brytyjska spółka działająca w branży biotechnologicznej, ogłosiła planowane na IV kwartał 2010 roku wejście na NewConnect, alternatywny rynek GPW.

15 December 2008
Lectus Therapeutics announces development milestone

10 September 2008
Lectus Therapeutics appoints new chairman, strengthens main and advisory boards

5 September 2007
Lectus Therapeutics secures £3million investment from the Wellcome Trust

24 July 2007
Lectus Therapeutics strengthens management team and SAB

15 May 2007
Lectus Therapeutics wins ERBI’s Innovation in Drug Discovery and Development Award.

8 January 2007
Lectus Therapeutics announces preclinical ‘Proof-of-Concept’ data.

26 September 2006
Lectus Therapeutics Announces Relocation to Cambridge.

19 April 2006
Lectus Therapeutics Acquires NeuroServe.

13 February 2006
Lectus Therapeutics closes Series A funding round raising £8.2 million.

2 August 2004
Lectus Therapeutics announces chemistry collaboration with Evotec OAI.

6 May 2004
Lectus Therapeutics announces strategic investment from Takeda Research Investment to advance discovery programmes for next-generation ion channel drugs.

3 November 2003
Lectus Therapeutics Ltd announces financing from the SULIS Seedcorn Fund.